Stuart Poulton
Executive VP & Chief Development OfficerMr. Stuart Poulton serves as Executive Vice President and Chief Development Officer of Karyopharm Therapeutics Inc. since August 2022 and served as its Global Head of Clinical operations & Portfolio Management and served as Senior Vice President of Strategy & Portfolio Management since February 2022 until August 2022. He has experience in the global biotech and pharmaceutical space. He joins Karyopharm from AbbVie, where he served as the Vice President of Clinical Development Operations and previously as the Vice President for Portfolio Program Management. Mr. Poulton also spent more than a decade at Amgen, where he held leadership roles of increasing responsibility in global program and portfolio management. He started his career in clinical operations at Eli Lilly. Mr. Poulton holds a Bachelor of Science in Pharmacology and Chemistry from the University of Sydney and a Master of Commerce in Marketing from the University of New South Wales.
Positions
- Company NameKaryopharm Therapeutics Inc.Stock CodeKPTIQPositionExecutive VP & Chief Development OfficerColleagues
- RARichard A. PaulsonPresident, CEO & Director
- RRReshma RangwalaExecutive VP, Chief Medical Officer & Head of Research
- SSSharon ShachamCo-Founder & Chairman of Scientific Advisory Board
- LALori A. MacomberEVP, CFO & Treasurer
- BEBarry E. GreeneLead Independent Director
- DRDeepika Rachel PakianathanIndependent Director
- GGGaren G. BohlinIndependent Director
